Evidence map›Paper›PMID 35104392›Full record

ArticleAdvanced healthcare materials2022

2D Covalent Organic Framework Direct Osteogenic Differentiation of Stem Cells.

Sukanya Bhunia, Manish K Jaiswal, Kanwar Abhay Singh, Kaivalya A Deo, Akhilesh K Gaharwar

Open access · greenAbstract read
In one paragraph

Article in Advanced healthcare materials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Nano-bio interactions of 2D molybdenum disulfide.Advanced drug delivery reviews · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Sukanya BhuniaBiomedical Engineering, College of Engineering, Texas A&M University, College Station, TX, 77843, USA.ORCID 0000-0002-1410-9715
Manish K JaiswalBiomedical Engineering, College of Engineering, Texas A&M University, College Station, TX, 77843, USA.ORCID 0000-0003-2304-6290
Kanwar Abhay SinghBiomedical Engineering, College of Engineering, Texas A&M University, College Station, TX, 77843, USA.ORCID 0000-0001-9704-0495
Kaivalya A DeoBiomedical Engineering, College of Engineering, Texas A&M University, College Station, TX, 77843, USA.ORCID 0000-0002-2233-383X
Akhilesh K GaharwarBiomedical Engineering, College of Engineering, Texas A&M University, College Station, TX, 77843, USA.ORCID 0000-0002-0284-0201
Texas A&M University · US

Funding

Mineralomics: Designing mineral based therapeutics to control and direct cell functionDP2EB026265 · NIBIB · TEXAS ENGINEERING EXPERIMENT STATION · PI GAHARWAR, AKHILESH K. · 2017 to 2021
$2.4M
NIBIB NIH HHS DP2 EB026265NIH HHS DP2 EB026265
6 · The paper itself

Abstract

2D covalent organic frameworks (COFs) are an emerging class of crystalline porous organic polymers with a wide-range of potential applications. However, poor processability, aqueous instability, and low water dispersibility greatly limit their practical biomedical implementation. Herein, a new class of hydrolytically stable 2D COFs for sustained delivery of drugs to direct stem cell fate is reported. Specifically, a boronate-based COF (COF-5) is stabilized using amphiphilic polymer Pluronic F127 (PLU) to produce COF-PLU nanoparticles with thickness of ≈25 nm and diameter ≈200 nm. These nanoparticles are internalized via clathrin-mediated endocytosis and have high cytocompatibility (half-inhibitory concentration ≈1 mg mL

Indexed as

Metal-Organic FrameworksDexamethasoneHumansOsteogenesisPolymersStem CellsDexamethasoneMetal-Organic FrameworksPolymers2D nanoparticlescovalent organic frameworks (COFs)drug deliverytissue engineering

Identifiers

PMID35104392
PMCPMC9354911
OpenAlexW4210302388

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.